Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications.

Downs, Callie G; Varisco, Tyler J; Bapat, Shweta S; Shen, Chan; Thornton, J Douglas

Downs, Callie G; Varisco, Tyler J; Bapat, Shweta S; Shen, Chan; Thornton, J Douglas.

Affiliation

Downs CG; College of Pharmacy, Prescription Drug Misuse Education and Research (PREMIER) Center, University of Houston, TX, USA. Electronic address: cgdowns@central.uh.edu.
Varisco TJ; College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy, University of Houston, TX, USA. Electronic address: tjvarisc@central.uh.edu.
Bapat SS; College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy, University of Houston, TX, USA. Electronic address: sbapat3@central.uh.edu.
Shen C; Division of Outcomes Research and Quality, Department of Surgery, Pennsylvania State College of Medicine, Hershey, PA, USA. Electronic address: cshen@pennstatehealth.psu.edu.
Thornton JD; College of Pharmacy, Prescription Drug Misuse Education and Research (PREMIER) Center, University of Houston, TX, USA; College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy, University of Houston, TX, USA. Electronic address: jdthornt@central.uh.edu.

Res Social Adm Pharm ; 17(1): 2005-2008, 2021 01.

Article in En | MEDLINE | ID: mdl-33317769

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzodiazepines / Practice Patterns, Physicians' / COVID-19 / Analgesics, Opioid Limits: Humans Country/Region as subject: America do norte Language: En Journal: Res Social Adm Pharm Journal subject: FARMACIA Year: 2021 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google